← Eichor
Study identifier: NCT05224934 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Preoperative Ultra-hypofractionated Radiotherapy Followed by Surgery for Retroperitoneal Sarcoma (FUSION-01)

Condition: Soft Tissue Sarcoma · Retroperitoneal Sarcoma · Radiotherapy Side Effect  ·  Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences

PhaseNA
Planned participants50
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

To investigate the feasibility and peri-operative complications of preoperative hypo-fractionated radiotherapy followed by surgery for retroperitoneal sarcoma

This description comes directly from the study's public registry record.

Talk to the study team

Ning-Ning Lu  ·  +868611804268  ·  Ning-Ning.Lu@hotmail.com

Shu-Lian Wang  ·  wsl20040118@yahoo.com

Always discuss trial participation with your own doctor first.

Locations (1)

Radiotherapy Department of Cancer Hospital, Chinese Academy of Medical SciencesBeijing, Beijing Municipality, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05224934